NCT05087173 is a NA clinical trial of Chatbot in COVID-19, sponsored by Sun Yat-sen University.

Who is sponsoring NCT05087173?

NCT05087173 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT05087173?

Interventions in NCT05087173: Chatbot.

Is NCT05087173 still recruiting?

NCT05087173 is currently status unknown. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05087173

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

Status unknown NA Last updated 18 January 2023

What this trial tests

NA trial testing Chatbot in COVID-19 in 1,200 participants. Status unknown.

Timeline

11 October 2021

Primary endpoint
31 August 2023

31 December 2023

Quick facts

Lead sponsor	Sun Yat-sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	1,200
Start date	11 October 2021
Primary completion	31 August 2023
Estimated completion	31 December 2023
Sites	1 location across China

Drugs / interventions tested

Chatbot

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Sun Yat-sen University

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the performance of an interactive chatbot and assess its effectiveness for enhancing informed decisions made by cataract patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Chatbot

Trials testing the same drug.

NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
NCT07059013 — A Chatbot-based Program to Promote Well-being in Caregivers of Children With Autism Spectrum Disorder · NA · recruiting
NCT06338462 — Cali Sin Tos Aim 2 · NA · completed
NCT06070441 — Adherence to Exercises for Neck Pain. · NA · completed
NCT06070415 — Adherence to Exercises for Low Back Pain. · NA · completed

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05087173 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05087173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing